🔎 Trials Near Me

ホーム › 鎌状赤血球症 › オハイオ

オハイオにおける鎌状赤血球症の臨床試験

オハイオ内の拠点で、鎌状赤血球症に関する22件の研究が参加者を募集しています。

オハイオ内の都市

公式研究テキスト(英語)

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07187973

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  • Univ Hosp Cleveland Med Ctr, Cleveland
  • Ohio State Univ Wexner Med Ctr, Columbus
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/17更新 · NCT06612268

Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)

  • University Hospitals Case Medical Center, Cleveland
被験者募集中観察研究健康なボランティア歓迎
12歳以上 · 全性別 · 2026/09/11更新 · NCT02824471

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Local Institution - 0028, Cleveland
被験者募集中第1/2相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/18更新 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Akron Children's Hospital - Showers Center for Cancer & Blood Disorders, Akron
  • Cincinnati Children's Hospital Medical Center, Hemophilia & Thrombosis Center, Cincinnati
  • University of Cincinnati Medical Center Hemophilia Treatment Center, Cincinnati
  • 他5件
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/17更新 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

  • University of Cincinnati, Cincinnati
  • The Ohio State University, Columbus
被験者募集中第2相
12歳以上 · 全性別 · 2026/08/14更新 · NCT06699849

Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

  • University of Cincinnati College of Medicine, Cincinnati
被験者募集中健康なボランティア歓迎
14歳〜80歳 · 全性別 · 2026/08/12更新 · NCT06725550

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

  • Ohio State University, Columbus
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07224360

Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease

  • Nationwide Children's Hospital, Columbus
被験者募集中第1/2相
12歳〜50歳 · 全性別 · 2026/07/02更新 · NCT04819841

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
全年齢 · 全性別 · 2026/06/18更新 · NCT04093986

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

  • Nationwide Children's Hospital (NT-DMT), Columbus
被験者募集中観察研究
3歳〜20歳 · 全性別 · 2026/06/04更新 · NCT06941389

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中
13歳〜21歳 · 全性別 · 2026/05/11更新 · NCT06290401

Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease

  • The Ohio State University Medical Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/03/23更新 · NCT06919224

Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial

  • Cincinnati Children's Hospital, Cincinnati
被験者募集中第2相
15歳〜40歳 · 全性別 · 2026/03/13更新 · NCT06260891

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

  • Nationwide Children's Hospital, Columbus
被験者募集中第2相
2歳〜25歳 · 全性別 · 2026/03/10更新 · NCT03587272

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

  • UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center, Cleveland
被験者募集中
14歳以上 · 全性別 · 2026/01/29更新 · NCT06853158

A Long-term Follow-up Study in Patients Who Received BEAM-101

  • University Hospitals Clevland Medical Center, Cleveland
  • The Clevland Clinic Foundation, Cleveland
被験者募集中観察研究
14歳〜37歳 · 全性別 · 2026/01/28更新 · NCT07373639

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
6 Months – 6 Years · 全性別 · 2026/01/21更新 · NCT07356050

Integrative Training Program for Pediatric Sickle Cell Pain

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中
12歳〜18歳 · 全性別 · 2025/11/14更新 · NCT06691867

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

  • Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第4相
6 Months · 全性別 · 2025/09/16更新 · NCT07177300

HPC Offered for PRESERVE Expansion

  • The Ohio State University Medical Center, Columbus
被験者募集中観察研究
12歳〜80歳 · 全性別 · 2025/08/28更新 · NCT07145411

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

  • Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2025/06/22更新 · NCT06385886

ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。